• Log In or Create Account
  • CROI
  • Conference on Bacteriophages
  • RWHAP CLINICAL CONFERENCE
  • Podcasts
  • Slides
  • Question of the Week
  • Guidelines
  • Contact
Advanced Search
15th Ryan White HIV/AIDS AETC Program Clinical CARE Conference: Moving Forward with CARE: Focusing on Passion, Purpose, and Excellence - IAS-USA
  • CME Courses
    • HIV In-Person and Virtual Courses
    • Current On-Demand Courses
    • About Courses
  • CME Webinars
    • Upcoming Webinars
    • Current On-Demand Webinars
    • MATE Act CME
    • About Webinars
  • Dialogues
    • Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
    • On-Demand Dialogues
    • About Dialogues
  • Topics In Antiviral Medicine
    • Current Issues for CME
    • Previous Issues
    • TAM Policies and Practices
    • Permission Request Form
  • HIV Drug Resistance
    • HIV Drug Resistance Resources
    • HIV Drug Resistance Mutations Chart
    • Recent Webinars
    • Journal Articles
  • Fellow Resources
    • Resources for Fellows and Others New to the HIV Field
    • On-Demand Webinars for Fellows
    • IAS-USA Guidelines and Recommendations
    • On-Demand Webcasts
    • Research Collaborations
    • Additional Resources
  • About
    • Scientific Leadership Board
    • IAS-USA Leadership Award Recipients
    • Core Faculty
    • Mission
    • Staff
    • CME
    • Funding Information
    • Careers
    • Website Policies
    • Discrimination and Harassment Policy
    • Governance
    • Suggestions and Recommendations from San Francisco Locals
    • Donate
    • FAQs

15th Ryan White HIV/AIDS AETC Program Clinical CARE Conference: Moving Forward with CARE: Focusing on Passion, Purpose, and Excellence

15th Ryan White HIV/AIDS AETC Program Clinical CARE Conference: Moving Forward with CARE: Focusing on Passion, Purpose, and Excellence

HIV/AIDS Bureau Update
Laura W. Cheever, MD, ScM

Update on HIV Cure Research
Robert F. Siliciano, MD, PhD

A Shot in the Arm for HIV Prevention? Opportunities and Challenges in 2016
Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA

State-of-the-ART in Antiretroviral Management
Joel E. Gallant, MD, MPH

Kidney Disease in HIV: An Update for Ryan White Providers
Christina M. Wyatt, MD

Cardiovascular Complications of HIV and Its Treatment
Marshall J. Glesby, MD, PhD

Neurologic Complications of HIV
Victor G. Valcour, MD, PhD

Persistent Challenges of HIV Transmission Control in Injection Drug Use: Lessons from the Indiana Outbreak
Diane M. Janowicz, MD

Elements of the Care Continuum
Michael J. Mugavero, MD, MHSc

Sexually Transmitted Infections
Kimberly A. Workowski, MD, FACP, FIDSA

Cases from the Clinic(ians): Case-based Panel Discussion
Michael S. Saag, MD

Chronic Pain in Patients With HIV: What Clinicians Need to Know
Jessica Merlin, MD, MBA

Get Your Patients With HIV/AIDS to Stop Smoking Before it Kills Them
Steven Schroeder, MD

State of the Art in Hepatitis C Virus Infection in HIV/HCV-Coinfected Patients
David L. Wyles, MD

What I Have Learned in 25 Years of HIV and Hepatitis C Psychiatry
Glenn J. Treisman, MD, PhD

Strategies for Staying Current in HIV Care – Panel Discussion
Steven P. Bromer, MD

15th Ryan White HIV/AIDS AETC Program Clinical CARE Conference: Moving Forward with CARE: Focusing on Passion, Purpose, and Excellence - IAS-USA

131 Steuart St, Suite 500, San Francisco, CA 94105

Phone: (415) 544-9400 | info@iasusa.org

  • Home
  • Activities
  • Resources
  • About
  • Contact
  • Login
  • Careers
  • Donate
  • Website Policies
© 2026 International Antiviral Society–USA. All Rights Reserved.
  • CROI
  • Conference on Bacteriophages
  • RWHAP CLINICAL CONFERENCE
  • Podcasts
  • Slides
  • Question of the Week
  • Guidelines
  • Contact
  • CME Courses
    • HIV In-Person and Virtual Courses
    • Current On-Demand Courses
    • About Courses
  • CME Webinars
    • Upcoming Webinars
    • Current On-Demand Webinars
    • MATE Act CME
    • About Webinars
  • Dialogues
    • Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
    • On-Demand Dialogues
    • About Dialogues
  • Topics In Antiviral Medicine
    • Current Issues for CME
    • Previous Issues
    • TAM Policies and Practices
    • Permission Request Form
  • HIV Drug Resistance
    • HIV Drug Resistance Resources
    • HIV Drug Resistance Mutations Chart
    • Recent Webinars
    • Journal Articles
  • Fellow Resources
    • Resources for Fellows and Others New to the HIV Field
    • On-Demand Webinars for Fellows
    • IAS-USA Guidelines and Recommendations
    • On-Demand Webcasts
    • Research Collaborations
    • Additional Resources
  • About
    • Scientific Leadership Board
    • IAS-USA Leadership Award Recipients
    • Core Faculty
    • Mission
    • Staff
    • CME
    • Funding Information
    • Careers
    • Website Policies
    • Discrimination and Harassment Policy
    • Governance
    • Suggestions and Recommendations from San Francisco Locals
    • Donate
    • FAQs
Practice Question of the Week

October 6, 2026: Drug-Drug Interactions With Antiretroviral Regimens

A 75-year-old person with HIV was no longer able to tolerate oral antiretroviral therapy and switched to lenacapavir (LEN) + cabotegravir (CAB) (intramuscular rilpivirine was not recommended due to the presence of nonnucleoside reverse transcriptase resistance mutations). Four weeks after the most recent injection, he had a cerebrovascular event. Clopidogrel was initiated by the neurologist. Which of the following best describes the risk of drug-drug interactions in this setting?
Register for the Chicago Course
View Archived Questions
Leave Feedback
Subscribe